| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| SYN-020 | SYN-020 | Phase 1 Clinical | Theriva Biologics Inc, Massachusetts General Hospital | Enteritis; Inflammatory Bowel Diseases; Metabolic Syndrome; Celiac Disease | Details |